Jubilant Therapeutics collaborates with Boston Children's Hospital
Metagenomi Adds Immuno-oncology Clinical Research Experts to its Scientific Advisory Board
Vividion Raises USD 135m in Series C Financing
First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States
US FDA Accepts for Priority Review NDA for Ruxolitinib Cream for Atopic Dermatitis
European Commission Purchases Additional 150m Doses of COVID-19 Vaccine Moderna